in accrued expenses and other current liabilities (1,459 ) 1,032 2,729 (2,338 ) 1,419 3,664 Net cash used in operating activities (40,749 ) (34,462 ) (44,769 ) INVESTING ACTIVITIES: Purchase of fixed …
More RedHill Biopharma Provides Full-Year 2019 Financial Results and Operational Highlights Videos